NT5E and B-cell chronic lymphocytic leukemia: CD73-deficient Eμ-TCL1tg/wt male mice, injected with a neutralizing anti-IFN-γ mAb, were no longer protected from CLL (Figure 4D,E and Figure S2H and Table 1).